Breast Cancer Clinical Trials

Showing 3521-3540 of 5,597 trials

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

NCT03740945

The purpose of this study is to confirm the efficacy of intravaginal prasterone (DHEA) on moderate to severe (MS) and most bothersome symptoms (MBS) of vulvovaginal atrophy (VVA) due to natural, surgical or treatment-induced menopause, in women with breast cancer who are under treatment with an aromatase inhibitor.

Vaginal Atrophy in Breast Cancer Patients

EndoCeutics Inc.Started Nov 2018

TERMINATEDPhase 2

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

NCT02685111

To compare the efficacy and safety of Day 2 (D2) once a cycle pegfilgrastim with Intermittent Every Other Days of 5 Shot (D3-11) filgrastim in early breast cancer patients treated with adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) regimen

Breast CancerNeutropeniaFebrile Neutropenia

Asan Medical Center22 participantsStarted Feb 2016

Seoul, South Korea

WITHDRAWNPhase 1

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

NCT00706615

RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating women with previously treated metastatic breast cancer.

Breast Cancer

Jonsson Comprehensive Cancer CenterStarted Jul 2008

Los Angeles, California, United States

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

Related Searches

Study of ESR1 Mutations in Metastatic Breast Cancer

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate

Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors

Whole Breast Irradiation vs Twice Daily vs. Once Daily Accelerated Partial Breast Irradiation

Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer

Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

Telenursing and Breast Cancer: The Turkish Case

A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors